Leading Benefit Providers Increasingly
Offer Medical Cannabis Coverage
TSX: ACB
EDMONTON, July 23, 2018 /CNW/ - Aurora Cannabis Inc.
("Aurora" or the "Company") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is proud to
announce that effective August 1,
2018, the company will offer a new employee benefits plan
that will include coverage for medical cannabis authorized by a
physician or nurse practitioner.
The new benefits plan, administered by Sun Life Financial,
will allow employees and their dependants to receive coverage for
medical cannabis under the Extended
Health Care plan.
"The speed with which Canada's largest insurers are moving to cover
the costs of medical cannabis reflects the increasing recognition
of cannabis-based therapies, and marks a significant milestone for
patients across the country, said Debra
Wilson, Senior VP of Human Resources. "Including medical
cannabis in the Company's benefits plan reflects our position as
one of the leading advocates for the availability of medical
cannabis, as well as employee health and wellness being major
pillars in Aurora's mission to be the employer of choice in the
sector."
Jonathan Zaid, Director of
Advocacy and Corporate Social Responsibility, added, "Offering
insurance coverage for medical cannabis, and making the
reimbursement process easy, is the right thing to do, and Aurora is
proud to be a leader in this area. At the same time, we recognize
there is still more work to be done to ensure patients across
Canada receive coverage for
medical cannabis, and we intend to continue supporting advocacy
initiatives in this area."
About Aurora
Headquartered in Edmonton,
Alberta, with funded capacity in excess of 430,000 kg per
year and sales and operations in 14 countries across five
continents, Aurora is one of the world's largest and leading
cannabis companies. Aurora is vertically integrated and
horizontally diversified across every key segment of the value
chain, from facility engineering and design to cannabis breeding
and genetics research, cannabis and hemp production, derivatives,
high value-add product development, home cultivation, wholesale and
retail distribution.
Highly differentiated from its peers, Aurora has
established a uniquely advanced, consistent and efficient
production strategy, based on purpose-built facilities that
integrate leading-edge technologies across all processes, defined
by extensive automation and customization, resulting in the massive
scale production of high quality product at ultra-low costs.
Intended to be replicable and scalable globally, these production
facilities are designed to produce cannabis of significant scale,
with high quality, industry-leading yields, and ultra-low per gram
production costs. Each of Aurora's facilities is built to meet
European Union (EU) GMP standards, and both its first production
facility and its wholly owned European medical cannabis distributor
Pedanios have achieved this level of certification.
In addition to the Company's rapid organic growth and
strong execution on strategic M&A, which to date includes nine
companies acquired - CanvasRX, Peloton Pharmaceutical, Pedanios, H2
Biopharma, Urban Cultivator, BC Northern Lights, Larssen, CanniMed
Therapeutics, and Anandia Labs - Aurora is distinguished by its
reputation as a partner of choice and employer of choice in the
global cannabis sector, having invested in and established
strategic partnerships with a range of leading innovators,
including: The Green Organic Dutchman Holdings Ltd. (TSX: TGOD),
Radient Technologies Inc. (TSXV: RTI), Hempco Food and Fiber Inc.
(TSXV: HEMP), Cann Group Ltd. (ASX: CAN), Micron Waste Technologies
Inc. (CSE: MWM), Choom Holdings Inc. (CSE: CHOO), Namaste
Technologies Inc. (TSXV: N), Evio Beauty Group (private), Wagner
Dimas (private), CTT Pharmaceuticals (OTCC: CTTH), and Alcanna Inc.
(TSX: CLIQ).
Aurora's Common Shares trade on the TSX under the symbol
"ACB", and are a constituent of the S&P/TSX Composite
Index.
For more information about Aurora, please visit our
investor website investor.auroramj.com.
Forward looking statements
This news release includes statements containing
certain "forward-looking information" within the meaning of
applicable securities law ("forward-looking statements").
Forward-looking statements are frequently characterized by words
such as "plan", "continue", "expect", "project", "intend",
"believe", "anticipate", "estimate", "may", "will", "potential",
"proposed" and other similar words, or statements that certain
events or conditions "may" or "will" occur. These statements are
only predictions. Various assumptions were used in drawing the
conclusions or making the projections contained in the
forward-looking statements throughout this news release.
Forward-looking statements are based on the opinions and estimates
of management at the date the statements are made, and are subject
to a variety of risks and uncertainties and other factors that
could cause actual events or results to differ materially from
those projected in the forward-looking statements. The Company is
under no obligation, and expressly disclaims any intention or
obligation, to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise,
except as expressly required by applicable law.
Neither TSX nor its Regulation Services Provider (as
that term is defined in the policies of Toronto Stock Exchange)
accepts responsibility for the adequacy or accuracy of this
release.
Terry Booth,
CEO
Aurora Cannabis Inc.
SOURCE Aurora Cannabis Inc.